about
Aberrant Autophagic Response in The Muscle of A Knock-in Mouse Model of Spinal and Bulbar Muscular Atrophy.Epileptogenic Q555X SYN1 mutant triggers imbalances in release dynamics and short-term plasticityGlycolytic-to-oxidative fiber-type switch and mTOR signaling activation are early-onset features of SBMA muscle modified by high-fat dietNew routes to therapy for spinal and bulbar muscular atrophy.REST-Dependent Presynaptic Homeostasis Induced by Chronic Neuronal Hyperactivity.Adenylyl cyclase activating polypeptide reduces phosphorylation and toxicity of the polyglutamine-expanded androgen receptor in spinobulbar muscular atrophy.Prelamin A is involved in early steps of muscle differentiation.Graphene Oxide Nanosheets Disrupt Lipid Composition, Ca(2+) Homeostasis, and Synaptic Transmission in Primary Cortical Neurons.Delivery of Brain-Derived Neurotrophic Factor by 3D Biocompatible Polymeric Scaffolds for Neural Tissue Engineering and Neuronal Regeneration.CD99 isoforms dictate opposite functions in tumour malignancy and metastases by activating or repressing c-Src kinase activity.Effect of starvation on brain glucose metabolism and 18F-2-fluoro-2-deoxyglucose uptake: an experimental in-vivo and ex-vivo study.Graphene Oxide Upregulates the Homeostatic Functions of Primary Astrocytes and Modulates Astrocyte-to-Neuron CommunicationAndrogens affect muscle, motor neuron, and survival in a mouse model of SOD1-related amyotrophic lateral sclerosismTOR as a Marker of Exercise and Fatigue in Octopus vulgaris ArmObligatory role of endoplasmic reticulum in brain FDG uptakeNeurite-Enriched MicroRNA-218 Stimulates Translation of the GluA2 Subunit and Increases Excitatory Synaptic StrengthNeuronal Cultures and NanomaterialsAn Increase in Membrane Cholesterol by Graphene Oxide Disrupts Calcium Homeostasis in Primary Astrocytes
P50
Q36189002-CE8673A9-8D6C-42E4-9BCB-C190EEEA36F5Q36839043-3FD869DC-59C8-40FB-AC23-3BC1C5DA1635Q37014362-70EF04A9-BAEB-40AA-A407-70449DC45720Q38082664-37688C5D-2160-40FC-A586-F001256113A7Q38635502-029183AF-7282-426B-BB66-F33EA261AD39Q46025171-72413C1D-8416-4314-AD1E-A05EA967820CQ46296157-B756A758-B362-4529-B9E4-F23EA34458F5Q51274301-DACC605E-1B09-4A09-9845-1EB06D725EAFQ51730626-62AADB42-4BFD-41D3-936E-7F297ECAD55AQ53333990-4E63955F-6711-4493-BD5E-95C9EC4F07E1Q55344172-72C0BFBE-0EE3-4AAE-830C-F8BB348A9466Q56342386-D9796438-1CA1-41E0-92B7-CE586AAD48EFQ57650052-255AB9D9-1C8F-436B-8467-EA7AEE535046Q90400154-68875C34-80D5-4DC8-85C0-33ADD7444E7AQ90932361-7E97F62C-F240-4154-86D4-9D961F2FE2CAQ91172990-B1478579-EB9B-49B7-B2E5-E8B5E334D820Q91906358-39A3FBB4-0510-4B81-B9EE-BF897339BB2BQ92495684-AD99CAB1-014B-4FE1-B0C2-2B5CBA4EEA4A
P50
description
investigador
@es
researcher
@en
name
Anna Rocchi
@en
Anna Rocchi
@nl
type
label
Anna Rocchi
@en
Anna Rocchi
@nl
prefLabel
Anna Rocchi
@en
Anna Rocchi
@nl
P31
P496
0000-0002-1334-9063